Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Worldwide Offices
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Top sports physio says football bosses failing to properly protect players' health this Christmas as injuries expected to rise


News provided by

Maxwellia

19 Dec, 2025, 08:30 GMT

Share this article

Share toX

Share this article

Share toX

CHESHIRE, England, Dec. 19, 2025 /PRNewswire/ -- A leading sports physiotherapist has criticised the Premier League and English Football League (EFL) for 'prioritising profit over players' by continuing to turn a blind eye to the effects of a squeezed Christmas fixture list, which he says is jeopardising players' health and wellbeing.

Continue Reading
This image opens in the lightbox
General shot from December's Brighton & Hove Albion vs Aston Villa match at the American Express Stadium, highlighting the 'Real Injury Time' campaign by Naprosyn Pain Relief. Copyright: Matt Alexander/PA Media Assignments

Martin Haines, a chartered physio and biomechanics coach, and former lead physiotherapist for both Crystal Palace and Arsenal, says the professional governing football bodies must rethink their approach to how end of year football matches are set. His comments come after a new Real Injury Time report, commissioned by Naprosyn Pain Relief, highlighted the risk of injury to players increases by a third (32 per cent) with fewer than four rest days between games.

This year, a total of 40 Premier League football matches are scheduled to be played between Saturday 20 December 2025 and Sunday 4 January 2026. In a change to previous seasons, fixtures have been organised to allow a minimum of 60 hours of rest between games, but Haines says this still isn't good enough and must be extended.

"Data shows that football is one of the most hazardous team sports at any time of the year," Haines says. "In men's football, a team is likely to lose a player every other game while for women, there's an injury every three games. This can be bad enough for any player and team, but it could intensify over the Christmas and New Year period with clubs forced to play several matches over a much shorter period. This insistence by the Premier League and EFL to squeeze as many games as possible into a few short weeks is simply a case of prioritising profit over players' health and wellbeing."

The Real Injury Time report, which is based on a research analysis by Dr Sean Williams, a leading academic in sports injury prevention from the University of Bath, and expert insights from Haines, also found that many players return to the pitch before their injuries have fully healed, risking further injury.

Haines says this is often due to players feeling under pressure to return: "It's all very well for fans and Premier League bosses to want their star players back on the pitch as soon as possible after injury, but it's one of the worst things you can do for their recovery. It's vital rehabilitation is slow and steady, otherwise players can either find themselves making their original injury worse or causing damage to other parts of their body due to the stress being placed on it. The medical teams realise this and perform excellent work to get players back as quickly as possible however, they are not usually able to make the final decision on when a player plays or not. At this time of year, when players are faced with such a hectic run of games and a higher risk of injury, making sure they are fully fit is more important than ever.

"To minimise the risk of reinjury, rehabilitation and recovery should be managed through a five-phased approach. This should start immediately after injury, incorporating appropriate pain relief, and can take a minimum of 6-8 weeks, depending upon the injury. A core principle is that pain management should not be used to mask symptoms but can be a helpful support in enabling appropriate rehabilitation and mobility when used correctly and as advised by a pharmacist."

Dr Sean Williams, Reader in Applied Statistics & Research Methods, University of Bath, adds: "The evidence shows that following a structured, phase-based approach to rehabilitation, rather than rushing back too quickly, is crucial for safe return to play. This means protecting the injury initially, then progressively building strength and function before returning to full training and matches. Professional or amateur, the rehabilitation principles are the same."

The Real Injury Time report was compiled from a variety of professional player data sources but are considered applicable to players at all levels. The report, commissioned by Naprosyn Pain Relief, covers the most common types of injuries and how they occur, when and why they tend to cluster, and optimal strategies to expedite recovery. It is available to download at https://naprosynpainrelief.com/real-injury-time.

For musculoskeletal injury, Naprosyn Pain Relief is available for the effective relief of short-term muscle pain, including sprains and strains and as an anti-inflammatory treatment. Its active ingredient, naproxen, is a well-established non-steroidal anti-inflammatory drug (NSAID) that has been prescribed for over 40 years for a range of musculoskeletal conditions. It offers dual-effect relief, targeting both pain and inflammation, and can provide powerful lasting relief for up to 12 hours with just one dose. By reducing the chemical messengers that cause inflammation, naproxen addresses the five hallmark signs — pain, swelling, redness, heat and loss of movement; helping people return to their normal activities.

For more information, please contact The Difference Collective:

  • Laura Gibson: 07771 933609 / laura.gibson@thedifferencecollective.com
  • Anna Gray: 07816 280576 / anna.gray@thedifferencecollective.com

Photo - https://mma.prnewswire.com/media/2849175/Maxwellia.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • PR Newswire Amplify™
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.